Houghton P J, Bailey F C, Germain G S, Grindey G B, Witt B C, Houghton J A
Dept. of Biochemical and Clinical Pharmacology, St Jude Children's Research Hospital, Memphis, Tennessee 38101.
Cancer Res. 1990 Jan 15;50(2):318-22.
Diarylsulfonylureas have been shown to have therapeutic activity against rodent and human tumor models, notably causing regressions in some lines of human colon adenocarcinomas in mice. At present the mechanism of cytotoxicity is unknown, although preliminary data implicate mitochondria as a potential site of action. In this study, the cytotoxicity of the diarylsulfonylurea N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea (ISCU) has been examined in GC3/c1 human colon adenocarcinoma cells. At cytotoxic concentrations of ISCU, in the presence of albumin as a drug binding species, there was only slight inhibition of [3H]thymidine and [3H]uridine incorporation at concentrations of ISCU up to 140 micrograms/ml and no inhibition of synthesis of protein as determined by incorporation of L-leucine. In the absence of albumin, incorporation of [3H]thymidine into DNA or [3H]uridine into RNA was inhibited at greater than 70 micrograms/ml and 140 micrograms/ml, respectively. As ISCU is highly bound to serum albumin (greater than 99%), it would appear that inhibition of nucleic acid synthesis occurs only at supralethal concentrations of ISCU. The cytotoxicity of ISCU in proliferating or quiescent cell populations was examined. GC3/c1 cells grown in medium containing 0.5% fetal calf serum (FCS) had a 60% reduction in rate of growth, but were more sensitive than cells exposed for 24 h in 10% FCS-medium (IC50 1.9 and 31 micrograms/ml, respectively). When the albumin concentration was adjusted (240 mg/100 ml) to allow equivalent drug binding, IC50 values were similar. In cultures of GC3/c1 cells growth rate was related to the concentration of FCS. In the absence of serum, growth rate was 2.5 to 3.2% that of exponentially growing control cultures in the presence of 10% FCS. Addition of FCS to quiescent cultures after 1 to 6 days in serum-free conditions resulted in immediate growth of cells. Clonogenic potential was also unchanged for at least 6 days under serum-free conditions. Under these conditions, where albumin concentration was adjusted to be equivalent to medium containing 10% FCS, sensitivity of proliferatively quiescent GC3/c1 cells was similar to that in exponentially growing control cultures in which the population doubling time was approximately 22 h. Further, there was no recovery of clonogenic potential when cells were exposed for 24 h to ISCU and maintained in a quiescent state for up to 4 days prior to serum stimulation. These data suggest that the cytotoxic effects of ISCU are independent of the proliferative state of the cell population.(ABSTRACT TRUNCATED AT 400 WORDS)
二芳基磺酰脲类已显示出对啮齿动物和人类肿瘤模型具有治疗活性,特别是能使某些品系的人结肠腺癌在小鼠体内发生消退。目前,细胞毒性机制尚不清楚,尽管初步数据表明线粒体是一个潜在的作用位点。在本研究中,已在GC3/c1人结肠腺癌细胞中检测了二芳基磺酰脲N-(5-茚满基磺酰基)-N'-(4-氯苯基)脲(ISCU)的细胞毒性。在ISCU的细胞毒性浓度下,在存在白蛋白作为药物结合物质的情况下,当ISCU浓度高达140微克/毫升时,[3H]胸腺嘧啶核苷和[3H]尿苷掺入仅受到轻微抑制,并且通过L-亮氨酸掺入测定的蛋白质合成没有受到抑制。在不存在白蛋白的情况下,[3H]胸腺嘧啶核苷掺入DNA或[3H]尿苷掺入RNA分别在大于70微克/毫升和140微克/毫升时受到抑制。由于ISCU与血清白蛋白高度结合(大于99%),似乎核酸合成的抑制仅在ISCU的超致死浓度下发生。检测了ISCU在增殖或静止细胞群体中的细胞毒性。在含有0.5%胎牛血清(FCS)的培养基中生长的GC3/c1细胞生长速率降低了60%,但比在10% FCS培养基中暴露24小时的细胞更敏感(IC50分别为1.9和31微克/毫升)。当调整白蛋白浓度(240毫克/100毫升)以实现等效的药物结合时,IC50值相似。在GC3/c1细胞培养物中,生长速率与FCS浓度相关。在无血清条件下,生长速率是存在10% FCS时指数生长对照培养物的2.5%至3.2%。在无血清条件下培养1至6天后向静止培养物中添加FCS导致细胞立即生长。在无血清条件下,克隆形成潜力至少6天也未改变。在这些条件下,将白蛋白浓度调整为相当于含有10% FCS的培养基,增殖静止的GC3/c1细胞的敏感性与群体倍增时间约为22小时的指数生长对照培养物中的敏感性相似。此外,当细胞暴露于ISCU 24小时并在血清刺激前保持静止状态长达4天时,克隆形成潜力没有恢复。这些数据表明,ISCU的细胞毒性作用与细胞群体的增殖状态无关。(摘要截断于400字)